Key result
SBP 140-169 is not linked to higher mortality in older CKD, whereas SBP <120 is.
Why the study?
Hypertension is associated with poor outcomes in CKD at ages under 70 years, but this association is unclear at older ages.
Does systolic blood pressure level affect mortality and cardiovascular outcomes in older adults with CKD stages 3 and 4?
Cohort (n=165,324)
Does systolic blood pressure level affect mortality and cardiovascular outcomes in older adults with CKD stages 3 and 4?
In older adults with CKD stages 3-4, moderate systolic hypertension (140-169 mmHg) does not increase mortality, whereas intensive lowering (<120 mmHg) is associated with higher mortality and cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Caution against SBP <120 mmHg in older CKD 3-4 adults; leaves optimal targets open for RCTs.
BACKGROUND: in chronic kidney disease (CKD), hypertension is associated with poor outcomes at ages <70 years. At older ages, this association is unclear. We tested 10-year mortality and cardiovascular outcomes by clinical systolic blood pressure (SBP) in older CKD Stages 3 and 4 patients without diabetes or proteinuria. METHODS: retrospective cohort in population representative primary care electronic medical records linked to hospital data from the UK. CKD staged by CKD-EPI equation (≥2 creatinine measurements ≥90 days apart). SBPs were 3-year medians before baseline, with mean follow-up 5.7 years. Cox competing models accounted for mortality. RESULTS: about 158,713 subjects with CKD3 and 6,611 with CKD4 met inclusion criteria. Mortality increased with increasing CKD stage in all subjects aged >60. In the 70 plus group with SBPs 140-169 mmHg, there was no increase in mortality, versus SBP 130-139. Similarly, SBPs 140-169 mmHg were not associated with increased incident heart failure, stroke or myocardial infarctions. SBPs <120 mmHg were associated with increased mortality and cardiovascular risk. At ages 60-69, there was increased mortality at SBP <120 and SBP >150 mmHg.Results were little altered after excluding those with declining SBPs during 5 years before baseline, or for longer-term outcomes (5-10 years after baseline). CONCLUSIONS: in older primary care patients, CKD3 or 4 was the dominant outcome predictor. SBP 140-169 mmHg having little additional predictive value, <120 mmHg was associated with increased mortality. Prospective studies of representative older adults with CKD are required to establish optimum BP targets.
No takes yet. Share an insight, caveat, or question.
Masoli et al. (2019) conducted a cohort in Chronic kidney disease Stages 3 and 4 (n=165,324). Systolic blood pressure vs. SBP 130-139 mmHg was evaluated on 10-year mortality and cardiovascular outcomes. In older adults with CKD stages 3 and 4, SBP 140-169 mmHg was not associated with increased mortality compared to 130-139 mmHg, while SBP <120 mmHg was associated with increased mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: